Mural Oncology (MURA) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Mural Oncology

NASDAQ: MURA · Real-Time Price · USD
2.09
0.00 (0.00%)
At close: Sep 26, 2025, 3:59 PM
2.09
0.00%
After-hours: Sep 26, 2025, 04:04 PM EDT

Mural Oncology Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
3.51M 2.57M 1.54M 1.47M
Gross Profit
-3.51M -2.57M -1.54M -1.47M
Operating Income
-138.26M -194.64M -184.92M -175.37M
Interest Income
9.75M n/a n/a n/a
Pretax Income
-128.51M -195.29M -184.92M -175.37M
Net Income
-128.51M -207.45M -200.03M -175.43M
Selling & General & Admin
27.6M 30.04M 25.08M 15.55M
Research & Development
110.67M 162.03M 170.07M 159.82M
Other Expenses
-3.51M n/a n/a -1.47M
Operating Expenses
134.75M 192.07M 195.15M 173.89M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a -667K n/a n/a
Cost & Expenses
138.26M 194.64M 184.92M 175.37M
Income Tax Expense
n/a 12.16M 4.88M 68K
Shares Outstanding (Basic)
16.95M 16.69M 16.69M 16.69M
Shares Outstanding (Diluted)
16.95M 16.69M 16.69M 16.69M
EPS (Basic)
-7.58 -12.43 -11.37 -10.51
EPS (Diluted)
-7.58 -12.43 -11.37 -10.51
EBITDA
-125M -192.72M -183.38M -173.89M
EBIT
-128.51M -195.29M -184.92M -175.37M
Depreciation & Amortization
3.51M 2.57M 1.54M 1.47M